|
HS Code |
735641 |
| Generic Name | Cefazolin Sodium Pentahydrate |
| Chemical Formula | C14H14N8Na2O9S3·5H2O |
| Molecular Weight | 534.6 g/mol (anhydrous basis) |
| Appearance | White to off-white crystalline powder |
| Solubility | Freely soluble in water |
| Pharmacological Class | First-generation cephalosporin antibiotic |
| Mechanism Of Action | Inhibits bacterial cell wall synthesis |
| Route Of Administration | Intravenous or intramuscular |
| Storage Temperature | 2°C to 25°C (36°F to 77°F) |
| Usage | Treatment of bacterial infections |
As an accredited Cefazolin Sodium Pentahydrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging contains **10 grams** of Cefazolin Sodium Pentahydrate, sealed in a sterile, amber glass vial with tamper-evident cap. |
| Shipping | Cefazolin Sodium Pentahydrate should be shipped in tightly sealed, moisture-resistant containers to prevent degradation. It must be protected from light and stored at controlled room temperature, avoiding excessive heat or freezing. Appropriate labeling and documentation in compliance with regulatory standards are essential during transport for safe handling and tracking. |
| Storage | Cefazolin Sodium Pentahydrate should be stored in a tightly closed container, protected from light and moisture. Store at controlled room temperature, ideally between 20°C and 25°C (68°F to 77°F). Avoid exposure to excessive heat. Keep the container in a dry place, away from incompatible substances and out of reach of unauthorized personnel. Proper storage ensures stability and efficacy. |
|
Purity 99%: Cefazolin Sodium Pentahydrate with purity 99% is used in parenteral antibiotic formulations, where it ensures minimized contamination and optimal therapeutic efficacy. Particle Size 10 µm: Cefazolin Sodium Pentahydrate with particle size 10 µm is used in intravenous suspension production, where it promotes rapid dissolution and uniform delivery. Stability Temperature 25°C: Cefazolin Sodium Pentahydrate with stability temperature 25°C is used in hospital storage environments, where it maintains chemical integrity and shelf-life. Water Content ≤ 13%: Cefazolin Sodium Pentahydrate with water content ≤ 13% is used in injectable powder compounding, where it guarantees reconstitution accuracy and product quality. Molecular Weight 476.5 g/mol: Cefazolin Sodium Pentahydrate with molecular weight 476.5 g/mol is used in pharmacokinetic research, where it delivers consistent dosing and reproducible bioavailability. USP Grade: Cefazolin Sodium Pentahydrate USP grade is used in regulated pharmaceutical manufacturing, where it assures compliance with pharmacopeial standards and patient safety. Melting Point 185°C: Cefazolin Sodium Pentahydrate with melting point 185°C is used in sterile powder isolation processes, where it confers stability during thermal handling procedures. Endotoxin Level < 0.5 EU/mg: Cefazolin Sodium Pentahydrate with endotoxin level < 0.5 EU/mg is used in injectable drug production, where it reduces risk of pyrogenic reactions in clinical applications. Bulk Density 0.45 g/cm³: Cefazolin Sodium Pentahydrate with bulk density 0.45 g/cm³ is used in powder filling operations, where it enables efficient volumetric dosage and process throughput. Loss on Drying ≤ 13%: Cefazolin Sodium Pentahydrate with loss on drying ≤ 13% is used in sterile product manufacture, where it assures consistency in final drug formulation and stability. |
Competitive Cefazolin Sodium Pentahydrate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Across hospitals and clinics, Cefazolin Sodium Pentahydrate stands as a dependable backbone in the fight against bacterial infections. Speaking as someone who's watched families and care teams place their hopes in successful antibiotic therapies, seeing this product in use feels like a reassurance. This isn’t just another name on a pharmacist’s shelf; it’s a clear choice in treating a range of serious infections — from deep tissue wounds after surgery to serious bacterial problems that threaten lives.
Cefazolin belongs to the class of first-generation cephalosporin antibiotics, which many clinicians trust for good reason. Its pentahydrate form means the molecule carries extra water — a detail that influences stability and reconstitution during preparation. The most common packaging comes in sterile vials, often holding 1g or 2g of active ingredient. Over years of handling similar medications, I’ve watched how this design makes dose calculations and administration smoother for both nurses and pharmacists.
As an injectable powder, Cefazolin Sodium Pentahydrate dissolves cleanly, so there’s less waiting around mixing and fewer clumps that can clog up syringes. This may sound minor until you realize nurses and doctors count on every second during emergencies. In my experience, fewer preparation errors add up to greater safety and less waste. Hospitals run on tight margins — both in terms of cash and timing — so reliability in something as basic as reconstitution actually matters in the big picture.
Cefazolin Sodium Pentahydrate finds regular use in the operating room, especially for surgical site infection prevention. Surgeons trust it for procedures ranging from orthopedic implants to heart and abdominal surgeries. Its spectrum of activity covers many of the most common culprits in hospital infections — notably Staphylococcus aureus and several strains of Streptococcus.
Outside of surgery, it pulls its weight across wards for treating skin and soft tissue infections, bone and joint infections, urinary tract infections, and certain respiratory infections when susceptible organisms are at play. From what I’ve seen, doctors often appreciate its track record in patients who need quick, reliable antibiotics, particularly when the immune system faces stress after an operation.
Antibiotics come in all stripes, and the landscape can get confusing. Cefazolin shows clear strengths compared with some other famous names. For example, ceftriaxone often pops up in discussions about broad-spectrum cephalosporins. But while ceftriaxone’s range covers more bugs, it often isn’t the first call for clean surgeries unless circumstances call for extra coverage. Vancomycin tackles MRSA, a nastier microbe that Cefazolin can’t touch, but vancomycin’s side effects and preparation routine prove harsher for many patients. Penicillins cover some overlapping ground, but allergies and resistance sometimes steer doctors away.
Clinicians weigh up these factors every day. Cefazolin wins points because, when you’re sure the infection involves certain “Gram-positive” bacteria — the kinds especially common on skin and hardware — it acts fast, giving predictable results with fewer side effects. Most patients appear to tolerate it well, and adverse reactions like severe allergic responses remain relatively uncommon. Compared with oral cephalosporins, the injectable form reaches blood concentrations that can knock out tougher infections. In my time working with these medications, I’ve noticed people often gravitate back to Cefazolin whenever circumstances allow, simply because fewer things go wrong down the line.
I’ve helped prepare countless doses behind pharmacy counters and on nursing shifts. What stands out about Cefazolin Sodium Pentahydrate involves how quickly pharmacy staff can reconstitute vials — a matter of swirling, not wrestling with stubborn powder or risking needle clogs. The sodium pentahydrate form brings predictable solubility, lending greater confidence in IV administration. There’s also a measure of safety in knowing the product’s pH profile lines up well with human blood, minimizing the risk of irritating veins, which sometimes plagues push-style antibiotics.
From a stewardship perspective, Cefazolin carries a lower risk for troublesome side effects like C. difficile overgrowth compared to broader-spectrum agents. This means that choosing it (where appropriate) ties directly into the responsible use of antibiotics, which remains central to countering the crisis of antimicrobial resistance. Having worked through several antibiotic shortages, I’ve seen hospitals forced to substitute broader agents, only to run into resistance and unintended gut complications.
Hospitals rely on products that last on the shelf and remain potent at the bedside. Based on years taking inventory, I’ve seen Cefazolin Sodium Pentahydrate withstand temperature fluctuations and keep stable through routine hospital handling practices, provided teams keep to the right storage recommendations. The pentahydrate form, largely due to those extra water molecules, tends to offer a little more stability under certain storage conditions compared with less hydrated versions. This reliability in supply chains makes it a favorite among purchasing managers trying to avoid shortages or rushed orders.
Nurses appreciate fewer surprises — vials don’t get “cake-y” or lumpy as easily, and they don’t see as many flakes after mixing, which saves valuable prep time. Stable medications also cut down on medication errors, which impact patient outcomes and contribute to hospital costs. Details like these rarely get attention in product listings, but real-world use brings them into focus.
No discussion of antibiotics can ignore the looming threat of resistance. As someone who’s worked alongside infectious disease teams, I know every time we opt for a focused drug like Cefazolin instead of a broad-spectrum “big gun,” we help preserve the tools that matter for future patients. Cefazolin’s narrow scope keeps pressure off bacterial populations that don’t call for treatment, which means we’re less likely to breed hardier, resistant strains. Every successful round with Cefazolin keeps ICU doctors from wringing their hands and reaching for the last-resort meds.
Resistance isn’t just a medical issue — it’s a public health challenge. Hospitals and clinics juggle stewardship programs, tracking how often and where antibiotics get prescribed. Cefazolin’s safety profile, effectiveness, and predictable results fit well with these efforts, helping doctors avoid unnecessary overuse of tougher, costlier therapies. There’s real satisfaction in seeing guidelines recommend it for targeted procedures, offering confidence both medically and operationally.
Unfortunately, no drug goes untouched by supply issues. Recent years have seen periodic shortages of major antibiotics, including Cefazolin Sodium Pentahydrate. Early in my career, a sudden shortage forced our hospital to scramble for alternatives, often swapping in higher-cost, broader antibiotics that strained both budgets and patients’ gut health. What gets missed in corporate reports is just how disruptive this can be for the daily running of wards, especially surgical units. Pharmacies see increased workloads as teams rush to re-educate staff, physicians face more complicated decisions, and patient safety can take a hit.
Securing a reliable supply chain is not a luxury; it’s a necessity that influences everything from hospital budgets to frontline safety. Policy changes favoring local manufacturing or more robust stockpiling could help ease these disruptions in the future. In crowded emergency departments, there’s no room for improvisation when the right antibiotics don’t arrive on time.
Patients and health programs share a common goal: keep expenses reasonable without cutting corners on care. Generic versions of Cefazolin Sodium Pentahydrate have widened access, making it far more affordable than newer, patent-protected antibiotics with less established safety histories. I’ve worked in both resource-rich and underfunded hospitals, and repeatedly see how affordable, time-tested antibiotics make the difference between rapid, effective intervention and needless suffering.
Its cost per dose remains low, especially alongside specialty agents designed for rare bacterial strains or drug-resistant bugs. This means medical teams can use Cefazolin broadly, supporting infection prevention programs and post-surgical recovery for large patient populations, not just those with premium insurance plans.
Drawing from direct experience, patients often tolerate Cefazolin Sodium Pentahydrate better than many alternatives. Infusion site reactions appear uncommon, nausea or other gut complaints tend to be mild, and the lack of taste (unlike some oral medications) keeps patients from turning up their noses. Pharmacies can stock ample supply without racking up storage or disposal hassles. For clinical staff, the workflow fits established routines and the need for special training rarely comes up.
For those with allergies to penicillins, Cefazolin can offer a safe alternative, although clinicians vigilantly review cross-reactivity risks. In rare cases, severe hypersensitivity may occur, but in careful hands, risk assessment and patient screening mitigate these outcomes. Over several years, I’ve seen seasoned nurses prefer Cefazolin for high-volume surgical settings because time spent mixing, checking, and administering is meaningfully lower than with some newer, complex agents.
Antibiotic overuse and waste disposal both pose environmental concerns. Older broad-spectrum products require disposal under hazardous guidelines, sometimes producing chemical waste that demands extra handling. Cefazolin Sodium Pentahydrate doesn’t require elaborate hazardous waste measures for routine disposal, which conserves both time and resources for hospitals trying to “go greener.” Pharmacies order just enough, cut down on expired stock, and reduce the risk of accidental exposure for staff. These features make a real difference over years of health system operations, especially in regions working to lower healthcare’s environmental footprint.
I’ve seen both small clinics and major teaching hospitals design standardized protocols centered on Cefazolin Sodium Pentahydrate. Infection control experts value its predictable pharmacokinetics, which means doctors can accurately dose it based on patient need and kidney function. Pharmacists use established referencing to calculate adjustments, and clinicians follow established timing guidelines, such as administering the drug 30 to 60 minutes before surgical incision.
Checklists and protocols streamline training, helping new staff get up to speed faster. Policymakers increasingly rely on evidence showing that standardized use of Cefazolin before surgery significantly reduces infection rates. Hospital committees update guidelines based on the latest resistance patterns and published clinical studies, underscoring Cefazolin’s staying power.
Though Cefazolin Sodium Pentahydrate has consistently performed well, product innovation could boost its role even further. Improving ready-to-use formats, such as pre-filled syringes or dual-chamber delivery devices, might relieve pressure on busy wards, especially during peak admission periods. Tweaks in vial design to reduce glass waste or allow lighter packaging could aid rural hospitals or global outreach projects.
Global health initiatives focus on maintaining the effectiveness of essential antibiotics while broadening access in low- and middle-income regions. Policymakers and pharmaceutical partners could collaborate to ensure stability testing matches the toughest shipping conditions. As resistance patterns shift, researchers could uncover new combinations or dosing regimens that pair Cefazolin with other agents for sustained effectiveness.
One of the lasting lessons from years spent working with clinicians is that education remains at the heart of responsible antibiotic use. Committing to ongoing training about proper reconstitution, dose adjustment in kidney impairment, and signs of allergy helps every health worker get the most from trusted medications like Cefazolin Sodium Pentahydrate. Interactive modules, peer reviewed guidelines, and practical workshops sustain competence across shifts and rotations.
Patient engagement is equally important. Involving patients in conversations about why clinicians choose Cefazolin, what to expect during and after treatment, and warning signs to watch for encourages shared responsibility for recovery and resistance prevention. Clear, transparent communication about how and why decisions get made reduces anxiety and fosters trust.
For all the dazzling new molecules and high-tech therapies transforming modern medicine, steady performers like Cefazolin Sodium Pentahydrate continue to anchor infection management. My ongoing experience shows that trust forms the backbone of medical decisions — trust in safety, trust in performance, trust in availability. This antibiotic offers all those things, which explains why it earns its place in hospital formularies, operating room trays, and the memory of care providers who’ve seen it work time and again.
Long after headlines hail the next breakthrough, those who work at the bedside know the value of tools that keep delivering. Cefazolin Sodium Pentahydrate sweeps through infection risk without drama, letting patients and providers refocus on healing. The healthcare world needs innovation, no doubt. Yet the quiet, steady impact of reliable choices gives everyone room to do their best work. Watching patients walk out the door stronger, and knowing small choices behind the scenes made that possible, gives a sense of satisfaction that numbers and charts alone just can’t explain.